Table 1.
Linear mixed model on the mean (95% confidence interval) changes in mHLA-DR at every measure point in the survivor and non-survivor groups
| Day 0 | Day 3 | Day 7 | |||||||
|---|---|---|---|---|---|---|---|---|---|
| Number | mHLA-DR | Number | mHLA-DR | Number | mHLA-DR | ΔmHLA-DR3 | ΔmHLA-DR7 | ΔmHLA-DR7-3 | |
| Survivor | 56 | 62.97 (56.38~69.55) |
56 | 69.42 (62.92~75.92) |
56 | 79.87 (73.96~85.78) |
6.45a (2.50~10.40) |
16.90b (11.85~21.95) |
10.45c (6.19~14.71) |
| Non-survivor | 23 | 56.77 (46.49~67.05) |
16 | 55.08 (44.26~65.90) |
10 | 61.32 (49.79~72.84) |
-1.69d (-8.95~5.57) |
4.55e (-5.96~15.06) |
6.24f (-3.28~15.76) |
| Between- groups difference |
8.14g (-0.12~16.40) |
12.35h (0.70~24.00) |
4.21i (-6.21~14.64) |
||||||
ΔmHLA-DR3 and ΔmHLA-DR7 were defined as the value change in mHLA-DR on days 3 and 7 compared with that on day 0, and ΔmHLA-DR7-3 was defined as the value change in mHLA-DR on day 7 compared with that on day 3. In the comparison of mean mHLA-DR differences in the same group between every measurement point, P values were a0.002, b < 0.001, c < 0.001, d0.644, e0.392, and f0.195. In the comparison of ΔmHLA-DR differences between two groups within the same measurement point, P values were g0.053, h0.038, and i0.423. CI, confidence interval; mHLA-DR, monocyte human leukocyte antigen-DR.